Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Epilepsy

• The Effect of Carnitine Supplementation on Cardiac Function and Lipid Profile in Patients With Drug Resistant Epilepsy on Ketogenic Diet
• Flunarizine for Treatment Resistant Absence Epilepsy
• Cognitive Function and Glymphatic System in Children With Epilepsy
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
• The Role of Vitamin D in Neuroinflammatory on Drug Resistant Epilepsy
• Epileptic Hippocampus in Alzheimer's Disease
• Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy
• Effect of Adding Lamotrigine to Sodium Valproate in Childhood Epilepsy: Clinicolabratory Study
• Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK
• A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies
• Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy
• An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.
• Impact of a Bi-annual CDTI on the Incidence of Epilepsy in an Onchocerciasis-endemic Area
• The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy
• A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Encephalopathy
• Add-on Clioquinol in Drug-resistant Childhood Epilepsy: an Exploratory Study
• Metformin Efficacy and Safety in Epileptic Patients
• An Open-label Study of XEN1101 in Epilepsy
• Cardiovascular Risk Reduction in Epilepsy
• The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
• Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy
• Exogenous Ketone Esters for Drug Resistant Epilepsy
• Bioequivalence Study of Sodium Valproate and Valproic Acid Tablets
• Clinical Study Evaluating and Comparing the Safety and the Possible Efficacy of Pentoxifylline in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy
• Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
• Adjunctive Everolimus Treatment of Refractory Epilepsy
• Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
• Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy (TrustTSC OLE)
• The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.
• Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy
• A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures
• Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
• Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy
• Safety and Pharmacokinetic Study of NPT 2042 Soft-gelatin Capsules Administered Orally to Healthy Adult Subjects
• Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia
• Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
• the Safety and Efficacy of N-acetyl Cysteine and Lactobacillus in Children With Drug-Resistant Epilepsy
• Getting SMART for Pediatric Epilepsy
• Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
• Study of Interest of Stiripentol and Carbamazepine in the Treatment of Patients With Pharmacoresistant Focal Epilepsies
• Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
• Diazepam Trial in GAD65 Associated Epilepsy
• Epidiolex® for Anxiety in Pediatric Epilepsy
• Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy
• Extension Study to Evaluate NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
• Helicobacter Pylori Eradication Therapy for Epileptic Children
• Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures
• Effects of Diazepam on RNS Detections
• Multicentre Study on Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy
• Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
• Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Subjects With SCN8A-DEE.
• Fycompa in Catamenial Epilepsy
• Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy
• A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
• A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
• Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
• A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy
• Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy
• Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy
• The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
• Effect of Pyridoxine on Behavioral Adverse Events of Levetiracetam
• Role of Clinical Pharmacists in Epilepsy Management
• Biperiden Trial for Epilepsy Prevention
• Epilepsy Prevalence and Intervention Study in Zhejiang Province, China
• Modification of Epilepsy Screen Questionnaire and Treatment Feasibility Evaluation
• An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
• Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
• Understanding Ketamine's Dissociative Effects (KD Study)
• Post-stroke Epilepsy: Primary Prophylaxis Study
• A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy
• Ciprofloxacin in Drug-resistant Epilepsy
• ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors
• A Study to Test the Safety and Tolerability of Brivaracetam in Pediatric Study Participants With Seizures
• Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
• Dexmedetomidine and Melatonin for Sleep Induction for EEG in Children
• Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
• XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
• A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment
• Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
• Changing Agendas on Sleep, Treatment and Learning in Epilepsy
• Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
• A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome
• Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children
• Anti-Epilepsy Medication Valproate Administered Via ICV Route and Catheters and Pumps for CSF Infusion
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures
• Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
• Perampanel Titration and Cognitive Effects
• Effect of Memantine on Cognitive Impairment in Patients With Epilepsy
• Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies
• A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
• A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil
• CBD Cannabis Extract: Pharmacokinetic Studies
• Ketogenic Diet for New-Onset Absence Epilepsy
• A Single-blind, Placebo-controlled, Outpatient Trial to Assess the Effects of Single Oral Tablet Dose of OPC-214870
• Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy
• Modified Atkins Diet Versus Levetiracetam for Refractory Childhood Epilepsy
• Effect of GABA on ADHD and Seizures in Children With Epilepsy.
• Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy
• Measuring Blood Flow in the Brain After Epileptic Activity
• A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
• Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE)
• Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy
• Cenobamate Open-Label Extension Study for YKP3089C025
• Diazepam Buccal Film (DBF) - Diastat Rectal Gel (DRG) Crossover Study
• Treating Postictal Symptoms Using Ibuprofen and Nifedipine
• A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome
• Voronistat in Pediatric Patients With Drug Resistant Epilepsy
• Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)
• Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy
• Cannabis Extract in Refractory Epilepsy Study
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy
• Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).
• Safety and Pharmacokinetics Study of E2007 to Treat Partial and Generalised Seizures in People With Epilepsy
• Memantine for Epileptic Encephalopathy
• A Study of Intravenous Perampanel in Japanese Participants With Epilepsy
• A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy
• Pharmacokinetics of Two Formulation of Pregabalin
• A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil
• Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)
• A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy
• A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization
• Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female Subjects
• Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies
• ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE)
• Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy
• A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
• A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy
• Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy
• Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint
• Vitamin D Supplementation to Prevent Vitamin D Deficiency for Children With Epilepsy
• Anxiety and Depression in Epilepsy: A Pilot Treatment Study
• Dexmedetomidine and Propofol for Pediatric MRI Sedation
• AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy
• Electroclinical Effect of Steroid in Patients With Benign Childhood Epilepsy With Centrotemporal Spikes
• An Investigation of Levetiracetam in Alzheimer's Disease
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern
• Vitamine D in Drug Resistant Epilepsy
• Anxiety and Depression in Epilepsy: A Treatment Study
• Fycompa Titration Intervals and Effects on Retention Rate
• Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy
• A Phase 2 Study of CX-8998 in Adolescents and Adults With Idiopathic Generalized Epilepsy With Absence Seizures
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy
• Pharmacokinetics and Tolerability of Sulthiame
• Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy
• Use of Clobazam for Epilepsy and Anxiety
• The Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy.
• Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy
• Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
• Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy
• Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy
• A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization
• A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients
• Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy
• Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy
• Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy
• Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies
• A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures
• A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
• A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy
• Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy
• Cannabidiol in Children With Refractory Epileptic Encephalopathy
• A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting
• Conscious Sedation for Epilepsy Surgery
• A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy
• Cannabinoid Therapy for Pediatric Epilepsy
• Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy
• Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy
• Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults
• Effects of Perampanel on Cognition and Electroencephalography in Patients With Epilepsy
• Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study
• A Dose Ranging Pilot Study for Intracerebroventricular (ICV) Delivery of Valproate in Subjects With Temporal Seizures
• Effect of Three Different Doses of Oral Cholecalciferol on 25-Hydroxyvitamin D Changes Among Epilepsy Patients With Hypovitaminosis D
• Fecal Microbiota Transplantation for Epilepsy
• Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
• A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy
• Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers
• Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome
• Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
• Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy
• Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization
• Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects
• Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects
• Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.
• Characterization of Epilepsy Patients BEEP 2b
• IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy
• Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody
• University of Alabama at Birmingham (UAB) Pediatric CBD Program
• A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome
• Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
• Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
• Prevention of Epileptic Seizures in Acute intraCerebral Haemorrhage
• An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
• An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
• A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
• Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)
• A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994
• Impact of Eslicarbazepine Acetate on Lipid Metabolism and Cardiovascular Risk Factors
• Efficacy of Fluoxetine Against Seizure-induced Central Apneas
• A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
• An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
• PF-06372865 in Subjects With Photosensitive Epilepsy
• Cannabidiol for Pediatric Epilepsy (Compassionate Use)
• TAK-935 Multiple Rising Dose Study in Healthy Participants
• Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
• The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy
• Ictal SPECT With Intra-arterial Injection
• A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935
• A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
• Eslicarbazepine Acetate (BIA 2-093) as Monotherapy in Patients With Newly Diagnosed Partial-onset Seizures
• Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures
• Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®)
• Treatment of Drug Resistant Epilepsy
• A Trial of Generic Substitution of Antiepileptic Drugs
• An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects
• Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures
• A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications
• BEEP Follow Up: Evaluation of Repeatability of Lamotrigine Pharmacokinetics in Epileptic Patients
• Epidiolex and Drug Resistant Epilepsy in Children
• Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users
• A Multicenter, Open-Label Proof-of-Concept Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies
• Staccato Alprazolam and Photoparoxysmal Response
• Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy
• Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy
• Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders
• Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
• Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics
• An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray.
• An Extended Access Program (EAP) for Perampanel
• Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation
• Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate
• The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin
• Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy
• Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate
• Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine
• Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function
• Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate Versus To-be-marketed Formulation
• Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.
• A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate
• Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.
• Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization
• Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine
• An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093
• Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive.
• An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093
• Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093
• CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients
• Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
• To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
• Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy
• Ketogenic Diet in Infants With Epilepsy (KIWE)
• A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy
• The Role of Melatonin in the Effective Attainment of Sleep Electroencephalograms (EEG) in Children
• Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures
• Methylphenidate Treatment of Attention Deficits in Epilepsy
• Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites
• The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin
• A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093
• A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093
• The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093
• A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093
• Pharmacokinetics, Efficacy and Tolerability of BIA 2-093
• A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters
• Development and Clinical Application of [11C]Verapamil-PET
• Clobazam Use in Epilepsia Partialis Continua - Pilot Study
• A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures
• Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study
• Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy
• The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg
• Treatment Resistant Epilepsy and N-Acetyl Cysteine
• A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years
• Traumatic Neuroprotection and Epilepsy Prevention of Valproate Acid
• Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours
• Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy
• Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU
• Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
• Lamotrigine Bioequivalence
• IV Lacosamide: The Safety of Intravenous Lacosamide
• A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.
• A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures
• Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures
• Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy
• Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures
• A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects
• Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy
• A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets
• Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)
• The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects
• A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy Volunteers
• A Sequential Multiple Ascending Dose Study of the Safety and Pharmacokinetics of Eslicarbazepine Acetate in Adult Healthy Volunteers
• The Effect of BIA 2-093 on the Steady-state Pharmacokinetic Profile of Phenytoin in Patients
• Comparison Between Lorazepam, Clonazepam and Clonazepam + Fosphenytoin for the Treatment of Out-of-hospital Generalized Status Epilepticus
• Special Drug Use Investigation for LAMICTAL® (Long Term)
• Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
• Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication
• Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures
• Cortical Excitability Changes Induced by Retigabine: a Transcranial Magnetic Stimulation Study
• Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients
• A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures
• Bioequivalence Study of 300 mg Gabapentin
• Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)
• Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy
• Lacosamide IV and EEG/EKG (LIVE) Study
• Trobalt™ Products Risk Survey
• Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design
• A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures
• A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy
• An Observational Study to Evaluate Long-term Retention Rate of Topiramate in Participants With Epilepsy
• Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
• Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
• Allopregnanolone for the Treatment of Traumatic Brain Injury
• Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy
• Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
• WEUSKOP6166: Lamotrigine and Aseptic Meningitis
• Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)
• Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures
• First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients
• WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide
• Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy
• An Open-label, Single-centre Study Evaluating the Pharmacokinetics of Digoxin Alone and When Administered at Various Doses of Ezogabine/Retigabine in Healthy Adults. The Pharmacokinetics of Ezogabine/Retigabine and the N-acetyl Metabolite of Ezogabi
• IVIG Treatment for Refractory Immune-Related Adult Epilepsy
• Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)
• Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
• Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures
• Imaging the Effect of Centrotemporal Spikes and Seizures on Language in Children
• An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy
• A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy
• Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy
• Buspirone Therapy for Localized Epilepsy
• Study in Pediatric Subjects With Epilepsy
• eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam
• Effect of Haemodialysis on the Pharmacokinetics of Ezogabine/Retigabine and Its N-acetyl Metabolite
• Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older
• A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Toni
• Levetiracetam to Prevent Post-Traumatic Epilepsy
• Crossover Study to Evaluate the Pharmacokinetics of Ezogabine/Retigabine in Taiwanese Subjects
• Risk of Urinary Retention With Retigabine
• Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304
• To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects
• Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan)
• Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients
• An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures
• Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy
• An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures
• Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
• A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures
• Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization
• Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database
• Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
• Drug Use Investigation for LAMICTAL
• Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy
• A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers
• Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China
• Add on Lacosamide Versus High Dose Monotherapy
• Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy
• Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS)
• An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.
• Preventive Treatment of Episodic and Chronic Migraine
• Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia
• Pharmacodynamics of Nasal and Buccal Midazolam Using EEG
• Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline
• Catamenial Epilepsy Treatment
• A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures
• Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy
• PRX-00023 Therapy in Localization-Related Epilepsy
• Once-A-Day Pregabalin For Partial Seizures
• Pharmacokinetics of Levetiracetam (Keppra) in Neonates
• Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures
• Lexapro for Major Depression in Patients With Epilepsy
• Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older
• A Study to Demonstrate Bioequivalence Between 6 x 2 mg Tablets of Perampanel and a Single 12 mg Tablet of Perampanel in Healthy Subjects
• Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure
• Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures
• A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)
• Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures
• Lyrica (Pregabalin) Korean Post Marketing Surveillance Study
• A Study to Investigate the Potential Pharmacokinetic Interaction of Perampanel With Oral Contraceptives in Healthy Female Subjects
• Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures
• Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy
• Cognitive and Behavioral Effects of Lacosamide
• Exploration of Genotype Based Personalized Prescription of Valproate Sodium in Anti-epileptic Treatment
• A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents
• Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities
• Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures
• Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy
• Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
• Effect on Anxiety in Partial Epilepsy Patients Treated With Pregabalin
• Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation
• Low and High Dose Zonisamide in Children as Monotherapy
• Study of Verapamil in Refractory Epilepsy
• A Study to Evaluate the Efficacy and Safety of Add-on Therapy of Wuling Capsule in Epilepsy Patients With Depression
• Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
• Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
• Dexmedetomidine in Seizure Patients
• A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)
• Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic
• A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy
• Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
• An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures
• Thalidomide Low Threshold in Epilepsy
• Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?
• Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy
• A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy
• An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
• Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children
• Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects
• Efficacy of Fluoxetine in Reducing Ictal Hypoventilation in Patients With Partial Epilepsy
• Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy
• Safety and Anticonvulsant Efficacy of Passiflora Incarnata Extract in Patients With Partial Epilepsy
• A Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy Patients
• Pilot Study of Melatonin and Epilepsy
• Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy
• Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures
• Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
• Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy
• Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study
• Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures
• A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients
• An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy
• A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures
• Clinical Study With Lyrica In Patients Suffering From Epilepsy
• Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects
• Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients
• Cognitive Effects of Treatment of Interictal Discharges
• To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions
• Eslicarbazepine Acetate Monotherapy Long Term Study
• The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin
• Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy
• Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine
• Effect of Repeat Administration of Eslicarbazepine Acetate on the Pharmacokinetics of a Combined Oral Contraceptive
• Lamotrigine Cognitive Function Study in Adult Untreated Epilepsies
• Photosensitivity Proof of Concept Trial
• Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery
• Double Blind, Crossover Study of Fish Oil [EPA and DHA] for Intractable Partial Seizures
• Valproate Sustained Release Minitablets (Orfiril(R) Long) Once Daily in the Evening
• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
• A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice
• Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures
• The Safety of Intravenous Lacosamide
• The Efficacy and Safety of Low Dose Combination of LTG and VPA Compared to CBZ Monotherapy
• A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927
• Determination of Absorption and Elimination of Lamotrigine-XR
• Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy
• Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures
• Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures
• An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam
• Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients
• An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures
• A Study of the Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.
• Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam
• Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate
• A Phase 1 Bioavailability Study of Topiramate Oral Liquid Formulation Compared to the Marketed Sprinkle Capsule Formulation in Healthy Adults
• A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures
• A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures
• Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
• Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset Seizures
• Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures
• Pediatric Switch Study for Children and Adolescent Patients With Epilepsy
• Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy
• Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type
• A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
• S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy
• Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy
• Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy
• AED/Statin Interaction Study
• Efficacy of YKP3089 in Patients With Photosensitive Epilepsy
• Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy
• Effect of Valproic Acid Concentration on Photic Response
• Bioequivalence and Food Effect of 250mg of Lamotrigine XR
• Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method
• Preventing Epilepsy After Traumatic Brain Injury With Topiramate
• Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures
• Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy
• Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures
• A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy
• GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
• Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)
• Prevention of Post-traumatic Seizures With Levetiracetam
• Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.
• Verapamil and Catamenial Epilepsy
• Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
• Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old
• Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis
• Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures
• Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
• Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures
• Study of Phenobarbital Inhibition of Catamenial Epilepsy
• P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.
• Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
• Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy Patients
• Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
• Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures
• Clobazam in Patients With Lennox-Gastaut Syndrome
• Lamotrigine Extended-Release In Elderly Patients With Epilepsy
• Open-label Extension to Protocol 1042-0600
• Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
• Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy
• Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
• A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy
• HEAD-Study Optimizing the Treatment of Children With BECTS
• A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures
• Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
• Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures
• Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)
• Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs
• Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures
• A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
• An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.
• A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
• Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.
• A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
• Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR
• Effect of Brivaracetam in Photosensitive Epileptic Subjects
• Clinical Evaluation of BW430C in Epilepsy
• EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
• Study of Valproate in Young Patients Suffering From Epilepsy
• Prediction of Childhood Epilepsy Outcome in Bangladesh
• Clinical Trial : TROCC (Quick Oral Treatment of Cluster Epileptic Seizures)
• A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR
• A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures
• A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy
• Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
• Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
• Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellectual Disability
• Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and Epilepsy
• Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
• Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures.
• Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial. 115097
• Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial
• Polyunsaturated Fatty Acids for Adjunctive Treatment of Refractory Epilepsy
• A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
• An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy
• A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures
• Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903).
• A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures
• Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
• Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures
• A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of Epilepsy
• A Study of the Efficacy and Safety of Topiramate Treatment in Patients With Epilepsy
• Lamotrigine and Oral Contraceptives
• Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy
• Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
• Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
• Lamotrigine Versus Levetiracetam in the Initial Monotherapy of Epilepsy
• Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients
• A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
• A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures
• A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.
• A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome
• A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With Epilepsy
• A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy
• A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy
• A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures
• A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
• A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures
• Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
• Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
• A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent Epilepsy
• A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure
• Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
• Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy Volunteers
• Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy
• A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment
• An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
• A Pilot Study of Topiramate in Childhood Absence Epilepsy
• An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
• Second-Line Treatment Choice for Epilepsy
• Levetiracetam for Benign Rolandic Epilepsy
• Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo
• A Study of Brivaracetam in Subjects With Partial Onset Seizures
• Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
• Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy
• Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.
• Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy
• A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
• Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization
• Clobazam in Subjects With Lennox-Gastaut Syndrome
• Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
• Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy
• Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
• Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures
• A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies
• Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures
• Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
• Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures
• Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS
• Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.
• This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatmen
• Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.
• Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults
• Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy
• Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy
• A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy
• Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
• E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures
• Pregabalin Open-Label Extension Trial in Patients With Partial Seizures
• To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
• To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures
• To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
• To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
• Hormone Profiles in Adults With Newly Diagnosed Epilepsy
• SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization
• Study to Improve the Treatment of Epilepsy (SITE)
• Effects on the Diagnostic Accuracy of Magnetic Imaging Angiographies of the Supra-Aortic Vessels by Three Different Magnetic Resonance Contrast Agents in Patients
• Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
• A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures
• Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures
• Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
• A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children
• Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy
• Pediatric Epilepsy Study
• Pediatric Epilepsy Study
• Pediatric Epilepsy Study in Subjects 1-24 Months
• Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy
• Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
• Pediatric Epilepsy Trial in Subjects 1-24 Months
• Early Surgical Intervention to Treat Epilepsy
• Hormone Replacement in Menopausal Women With Epilepsy
• Depression and Health Outcomes in Refractory Epilepsy
• Brain Infusion of Muscimol to Treat Epilepsy
• Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
• Phase II Randomized Study of Early Surgery Vs Multiple Sequential Antiepileptic Drug Therapy for Infantile Spasms Refractory to Standard Treatment
• Double-Blind, Placebo-Controlled Trial of Vitamin E as Add-on Therapy for Children With Epilepsy
• Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
• Metabolic Abnormalities in Children With Epilepsy
• Brain Blood Flow Studies of Language and Memory